Gender and racial pay disparities continue to affect the life sciences sector, according to the BioSpace 2026 U.S. Life Sciences Salary Report released on Apr. 23. The report shows that in 2025, the gender pay gap remained unchanged for a third consecutive year, while white/non-Hispanic professionals continued to earn more than other groups.
These findings underscore ongoing concerns about equity within the industry. Tom Browne, founder of Corporate to Community Services and former diversity consultant for MassBio, said that while there is broad awareness of these issues, action has lagged behind understanding. "I think that there’s a gap between understanding and action, and until we close that gap, we’re going to continue to see the inequities that your report is illustrating," Browne said.
A separate 2024 BIO report also called attention to pay equity challenges in biotech companies. The report stated: "Pay equity is an increasingly important concern for organizations, with more countries implementing regulations mandating monitoring, compliance, and transparency related to compensation." It added that unresolved pay equity issues can erode trust in leadership and expose organizations to litigation risks.
The BioSpace survey found females earn about 88% of what males make when salaries and bonuses are combined—$170,058 on average compared with $195,942 for males. The data also showed male respondents generally had more experience in life sciences roles. Browne suggested this experience gap contributes significantly but noted it will take time for workforce development programs aimed at supporting women’s advancement to show results.
Racial disparities were also evident: white/non-Hispanic professionals earned an average of $203,287; Latino or Hispanic workers averaged $166,118; Asian professionals earned $157,721; Black or African American workers made $145,537 on average. The survey indicated these differences partly reflect variations in experience levels among respondents as well as representation rates across groups.
Browne said structural factors underpin both gender and racial gaps but pointed out growing recognition within life sciences firms of the need for diverse talent—especially amid global competition for skilled employees. He emphasized urgency: "Once talent leaves our hubs here in the U.S., my concern is that it’s very difficult to then get them back." Despite ongoing challenges, Browne expressed optimism about progress due to increased investment in early-stage talent development and greater willingness by companies to examine internal barriers affecting women or minorities.
